Comparable stake leader
Vincent S. LoPriore
SEC ownership of Hepion Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001583771.
Disclosed value leader
Vincent S. LoPriore
Comparable rows
6/20
Latest evidence
19 Aug 2026
- Public ticker
- HEPA, CTRVP on OTC
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Vincent S. LoPriore
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
6 of 20
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Vincent S. LoPriore
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
19 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001583771
- Issuer location
- Red Bank, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Hepion Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vincent S. LoPriore
Disclosed value leader
Vincent S. LoPriore
Comparable rows
6/20
Latest evidence
19 Aug 2026
13D/G
3/4/5
Lead comparable stake: 26%
14 rows are not safely comparable across share classes.
13D/G row: Vincent S. LoPriore
Showing 1-8 of 20 holder rows.
Quick read
Vincent S. LoPriore leads the comparable SEC ownership view at 26%.
6 of 20 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vincent S. LoPriore's linked filing trail.
Comparable ownership
Top 5
Vincent S. LoPriore
26%
Black Global 5 LLC
11%
BIGGER CAPITAL FUND L P
10%
Gary S. Stetz
5.7%
Sireesh Appajosyula
5.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 20 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vincent S. LoPriore |
13D/G
3/4/5
Vincent LoPriore · Executive Chairman, Director
|
26%
|
$1,837,500
26,250,000 shares
|
$0 | 03 Aug 2026 |
| Black Global 5 LLC |
13D/G
3/4/5
10%+ Owner
|
11%
|
$700,000
10,000,000 shares
|
$0 | 31 Jul 2026 |
| BIGGER CAPITAL FUND L P |
13D/G
|
10%
|
$21,218
1,060,883 shares
|
$0 | 21 Jan 2025 |
| Gary S. Stetz |
13D/G
3/4/5
Gary Stetz · Interim CEO, Director
|
5.7%
|
$367,500
5,250,000 shares
|
$0 | 03 Aug 2026 |
| Sireesh Appajosyula |
13D/G
3/4/5
Chief Operating Officer, Director
|
5.7%
|
$367,500
5,250,000 shares
|
$0 | 03 Aug 2026 |
| Anson Funds Management LP |
13D/G
|
4.9%
|
—
576,482 shares
|
$0 | 30 Jun 2025 |
| Michael J. Purcell |
3/4/5
Director
|
—
mixed-class rows
|
$162,500
5,599,000 shares
mixed-class rows
|
+$150,000 | 19 Aug 2026 |
| Dr. Robert T. Foster |
3/4/5
CEO and Director, Director
|
—
class O/S missing
|
$153,934
50,470 shares
|
— | 18 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$1,225,000.
Buys
$1,225,000
Insiders: 5
Sells
$0
Insiders: 0
Net
+$1,225,000
Shares: +26,500,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 26,500,000
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 16,500,000 | 0 | $825,000 | $0 | +$825,000 |
| 3-6 | 10,000,000 | 0 | $400,000 | $0 | +$400,000 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to Hepion Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Vincent S. LoPriore
Net 12M change
+$1,225,000
Latest report
19 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Vincent S. LoPriore | Executive Chairman, Director | $1,525,000 | +$750,000 | +97% | Filing P/S | 19 Aug 2026 |
| Gary S. Stetz | Interim CEO, Director | $212,500 | +$150,000 | +240% | Filing P/S | 19 Aug 2026 |
| Black Global 5 LLC | 10%+ Owner | $200,000 | Market | 03 Aug 2026 | ||
| Michael J. Purcell | Director | $162,500 | +$150,000 | +1200% | Filing P/S | 19 Aug 2026 |
| Sireesh Appajosyula | Chief Operating Officer, Director | $162,500 | +$150,000 | +1200% | Filing P/S | 19 Aug 2026 |
| Dr. Robert T. Foster | CEO and Director, Director | $153,934 | Mixed | 18 Sep 2023 | ||
| Peter Wijngaard | Director | $28,978 | Filing P/S | 24 Nov 2023 | ||
| Gary S. Stetz II | Director | $25,000 | +$25,000 | +100% | Filing P/S | 19 Aug 2026 |
| Chase LoPriore | VP, Corp. Dev., Director | $25,000 | Market | 19 Aug 2026 | ||
| Danina Fisher | Director | Mixed | 19 Aug 2026 | |||
| Anand Reddi | Director | Mixed | 27 Jun 2022 | |||
| Gary S. Jacob | Director | Mixed | 19 Feb 2024 | |||
| Cavan John T. | Chief Financial Officer | Mixed | 18 May 2021 | |||
| Timothy M. Block | Director | Mixed | 19 Feb 2024 | |||
| Thomas Adams PhD | Director | Mixed | 18 May 2021 | |||
| Arnold Lippa | Director | Mixed | 18 May 2021 | |||
| John P. Brancaccio | Chairman, Director | Mixed | 19 Feb 2024 | |||
| Kaouthar Lbiati | Director | Mixed | 19 Feb 2024 | |||
| James G. Liddy | Director | Mixed | 19 Aug 2026 |
Recent insider transactions for Hepion Pharmaceuticals, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael J. Purcell | HEPA | Stock Options | Award | 299,000 | 299,000 | 19 Aug 2026 | Direct | |||
| Gary S. Stetz | HEPA | Stock Options | Award | 1,345,500 | 1,345,500 | 19 Aug 2026 | Direct | |||
| Vincent S. LoPriore | HEPA | Stock Options | Award | 1,345,500 | 1,345,500 | 19 Aug 2026 | Direct | |||
| Chase LoPriore | HEPA | Stock Options | Award | 1,345,500 | 1,345,500 | 19 Aug 2026 | Direct | |||
| Danina Fisher | HEPA | Stock Options | Award | 299,000 | 299,000 | 19 Aug 2026 | Direct | |||
| James G. Liddy | HEPA | Stock Options | Award | 299,000 | 299,000 | 19 Aug 2026 | Direct | |||
| Sireesh Appajosyula | HEPA | Stock Options | Award | 1,345,500 | 1,345,500 | 19 Aug 2026 | Direct | |||
| Gary S. Stetz II | HEPA | Stock Options | Award | 299,000 | 299,000 | 19 Aug 2026 | Direct | |||
| Gary S. Stetz II | HEPA | Common Stock | Purchase | $25,000 | $0.0500 | 500,000 | 500,000 | 03 Aug 2026 | Direct | |
| Gary S. Stetz II | HEPA | Warrants | Purchase | 500,000 | 500,000 | 03 Aug 2026 | Direct | |||
| Michael J. Purcell | HEPA | Common Stock | Purchase | 160% | $100,000 | $0.0500 | 2,000,000 | 3,250,000 | 03 Aug 2026 | Direct |
| Michael J. Purcell | HEPA | Warrants | Purchase | 2,000,000 | 2,000,000 | 03 Aug 2026 | Direct | |||
| Sireesh Appajosyula | HEPA | Common Stock | Purchase | 160% | $100,000 | $0.0500 | 2,000,000 | 3,250,000 | 03 Aug 2026 | Direct |
| Sireesh Appajosyula | HEPA | Warrants | Purchase | 2,000,000 | 2,000,000 | 03 Aug 2026 | Direct | |||
| Vincent S. LoPriore | HEPA | Common Stock | Purchase | 14% | $100,000 | $0.0500 | 2,000,000 | 16,250,000 | 03 Aug 2026 | By Invictus Capital Advisors Pension Plan |
| Vincent S. LoPriore | HEPA | Common Stock | Purchase | 128% | $400,000 | $0.0500 | 8,000,000 | 14,250,000 | 03 Aug 2026 | By Gravitas Capital LP |
| Vincent S. LoPriore | HEPA | Warrants | Purchase | 25% | 2,000,000 | 10,000,000 | 03 Aug 2026 | By Invictus Capital Advisors Pension Plan | ||
| Vincent S. LoPriore | HEPA | Warrants | Purchase | 8,000,000 | 8,000,000 | 03 Aug 2026 | By Gravitas Capital LP | |||
| Gary S. Stetz | HEPA | Common Stock | Purchase | 160% | $100,000 | $0.0500 | 2,000,000 | 3,250,000 | 03 Aug 2026 | Direct |
| Gary S. Stetz | HEPA | Warrants | Purchase | 2,000,000 | 2,000,000 | 03 Aug 2026 | Direct | |||
| Michael J. Purcell | HEPA | Common Stock, par value $0.0001 per share | Purchase | $50,000 | $0.0400 | 1,250,000 | 1,250,000 | 21 Apr 2026 | Direct | |
| Vincent S. LoPriore | HEPA | Common Stock, par value $0.0001 per share | Purchase | 25% | $50,000 | $0.0400 | 1,250,000 | 6,250,000 | 21 Apr 2026 | By Invictus Capital Advisors Pension Plan |
| Vincent S. LoPriore | HEPA | Common Stock, par value $0.0001 per share | Purchase | $200,000 | $0.0400 | 5,000,000 | 5,000,000 | 21 Apr 2026 | By Gravitas Capital LP | |
| Sireesh Appajosyula | HEPA | Common Stock, par value $0.0001 per share | Purchase | $50,000 | $0.0400 | 1,250,000 | 1,250,000 | 21 Apr 2026 | Direct | |
| Gary S. Stetz | HEPA | Common Stock, par value $0.0001 per share | Purchase | $50,000 | $0.0400 | 1,250,000 | 1,250,000 | 21 Apr 2026 | See Footnote |
* marks a reported price that did not pass the local price check.